Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,General Medicine
Reference6 articles.
1. Brunello J, Guerby P, Cartoux C, Yazigi A, Baujat M, Parant O, Vayssiere C, Vaysse C, Chantalat E, Vidal F (2019) Can early betahCG change and baseline progesterone level predict treatment outcome in patients receiving single dose methotrexate protocol for tubal ectopic pregnancy? Arch Gynecol Obstet.
https://doi.org/10.1007/s00404-019-05068-1
2. Food and Drug Administration Methotrexate Injection, USP. FDA, Reference ID: 3033070.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/011719s117lbl.pdf
. Accessed 12 July 2019
3. Agency (EMA) EM (2018) Methotrexate containing products, EMA reviewing risk of dosing errors with methotrexate, EMA/215649/2018.
https://www.ema.europa.eu/en/documents/press-release/ema-reviewing-risk-dosing-errors-methotrexate_en.pdf
. Accessed 12 July 2019
4. Marret H, Fauconnier A, Dubernard G, Misme H, Lagarce L, Lesavre M, Fernandez H, Mimoun C, Tourette C, Curinier S, Rabishong B, Agostini A (2015) Evidence-based evaluation and expertise of methotrexate off label use in gynecology and obstetrics: work of the CNGOF. J Gynécol Obstét Biol Reprod (Paris) 44:230–236
5. Levin G, Chill HH, Rottenstreich A (2017) Transverse myelitis following methotrexate treatment of ectopic pregnancy: a case report. Eur J Contracept Reprod Health Care 22:476–478
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献